The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma
Top Cited Papers
Open Access
- 1 December 2005
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 18 (12), 1591-1598
- https://doi.org/10.1038/modpathol.3800436
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Hepatocyte Antigen as a Marker of Hepatocellular CarcinomaThe American Journal of Surgical Pathology, 2002
- Membrane Heparan Sulfate Proteoglycan-supported FGF2-FGFR1 SignalingOnline Journal of Public Health Informatics, 2001
- Glypicans: proteoglycans with a surpriseJCI Insight, 2001
- Glypican-3 Modulates BMP- and FGF-Mediated Effects during Renal Branching MorphogenesisDevelopmental Biology, 2001
- Hepatocellular carcinomaJournal of Hepatology, 2000
- glypican-3 Controls Cellular Responses to Bmp4 in Limb Patterning and Skeletal DevelopmentDevelopmental Biology, 2000
- Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesotheliomaOncogene, 2000
- Utility of CD34 Reactivity in Evaluating Focal Nodular Hepatocellular Lesions Sampled by Fine Needle Aspiration BiopsyActa Cytologica, 2000
- Hepatocellular carcinomaThe Lancet, 1999
- Neoangiogenesis and Sinusoidal "Capillarization" in Dysplastic Nodules of the LiverThe American Journal of Surgical Pathology, 1998